How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy by Fahad Aziz, MD, Sandesh Parajuli, MD, Neetika Garg, MD, Maha Mohamed, MD, Weixiong Zhong, MD, Arjang Djamali, MD, Didier Mandelbrot, MD

Get full text

The Trend of Serum Creatinine Does Not Predict Follow-Up Biopsy Findings Among Kidney Transplant Recipients With Antibody-Mediated Rejection by Sandesh Parajuli, MD, Weixiong Zhong, MD, Monika Pantha, BS, Megan Sokup, PA, Fahad Aziz, MD, Neetika Garg, MD, Maha Mohamed, MD, Didier Mandelbrot, MD

Get full text

Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia by Emily Joachim, MD, Sandesh Parajuli, MBBS, Kurtis J. Swanson, MD, Fahad Aziz, MBBS, Neetika Garg, MBBS, Maha Mohamed, MD, Didier Mandelbrot, MD, Arjang Djamali, MD

Get full text

Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia by Eman A. Alshaikh, MD, Brad C. Astor, PhD, Brenda Muth, NP, Margaret Jorgenson, PharmD, Kurt Swanson, MD, Neetika Garg, MD, Fahad Aziz, MD, Maha Mohamed, MD, Didier Mandelbrot, MD, Sandesh Parajuli, MD

Get full text

Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies by Fahad Aziz, MD, Sandesh Parajuli, MD, Margaret Jorgenson, PharmD, BCPS, Neetika Garg, MD, Venkata Manchala, MD, Elsadiq Yousif, MD, Didier Mandelbrot, MD, Luis Hidalgo, PhD, Maha Mohamed, MD, Weixiong Zhong, MD, Arjang Djamali, MD

Get full text